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DObjective: Patients with severe heart failure might benefit from reduced operative trauma, but rarely undergo
less-invasive valve surgery. The present study compared the outcomes of less-invasive heart valve surgery with
those of complete sternotomy in such patients.
Methods: From January 1995 to July 2010, 871 patients in New York Heart Association class III or IV
underwent valve surgery (aortic or mitral, or both). A less-invasive approach was used in 205. Propensity score
matching yielded 185 matched pairs for outcomes comparison adjusted for patient characteristics and 139 pairs
adjusted further for individual surgeon.
Results:Without considering surgeons, myocardial ischemic times (59  27 vs 64  26 minutes, P ¼ .04),
cardiopulmonary bypass times (75  35 vs 86  34 minutes, P< .0001), and intensive care unit stays
(median, 24 vs 43 hours; P ¼ .007) were shorter for less-invasive surgery. Hospital morbidity, mortality
(1.6% [3 of 185] vs 2.7% [5 of 185]; P ¼ .5), and long-term survival (53% and 48% at 12 years;
P ¼ .3) were similar. After considering the surgeon, these benefits were not apparent; rather, efficiency,
safety, and effectiveness were equivalent to those of complete sternotomy. Thus, myocardial ischemic
(63  30 vs 62  25 minutes, P ¼ .8) and cardiopulmonary bypass (80  40 vs 81  31 minutes,
P ¼ .5) times were similar, as were intensive care unit stay (median, 28 vs 30 hours; P ¼ .09), postoperative
complications, in-hospital mortality (2.2% [3 of 139] vs 3.6% [5 of 139]; P ¼ .5), and long-term survival
(57% and 53% at 12 years; P ¼ .5).
Conclusions: In selected patients with severe heart failure, less-invasive valve surgery is a viable option,
yielding at least equivalent efficiency, safety, and effectiveness to complete sternotomy. However, achieving
these outcomes requires surgeons experienced in less-invasive surgery. (J Thorac Cardiovasc Surg
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The Journal of Thoracic and CaLess-invasive heart valve surgery has been associated with
less operative trauma, fewer complications, and shorter
postoperative hospitalization than operations performed
through a complete sternotomy.1-5 Nevertheless, patients
with severe heart failure, who might be expected to
benefit most from a reduction in operative trauma, rarely
undergo less-invasive valve surgery.
The goals of the present study were to (1) compare the
efficiency, safety, and effectiveness of less-invasive approa-
ches to those of complete sternotomy in patients with severe
heart failure undergoing primary isolated aortic valve or
mitral valve surgery, or both; and (2) explore surgeon pref-
erence to identify circumstances in which 1 approach might
be optimum.METHODS
Study Population
From January 1995 to July 2010, 10,791 adults underwent primary iso-
latedmitral valve repair or replacement, primary isolated aortic valve repair
or replacement, or a combined primary procedure for rheumatic, degenera-
tive, or functional valve diseasewith or without concomitant tricuspid valve
surgery at Cleveland Clinic (Figure E1). Percutaneous aortic valverdiovascular Surgery c Volume 148, Number 1 161
Abbreviations and Acronyms
CL ¼ confidence limits
CPB ¼ cardiopulmonary bypass
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Dinsertion, procedures that included mitral annular debridement, and emer-
gency operations were excluded. Of the remaining 10,714 patients, 871
had symptomatic heart failure (New York Heart Association class III or
IV) within 2 weeks before surgery. Less-invasive surgery was performed
in 205 patients (23%) and complete sternotomy in 666 (77%). A total of
267 mitral valve replacements (43%), 342 mitral valve repairs (57%),
417 aortic valve replacements (96%), and 15 aortic valve repairs (4%)
were performed. The characteristics of these 871 patients and operative de-
tails are presented in Table E1. These patients constituted, in part, a sub-
group of previously reported investigations of less-invasive cardiac valve
surgery, and the operations were classified on an as-treated basis.1,2,6
Data Sources
Clinical data were obtained from the Cardiovascular Information Reg-
istry, a prospective database updated concurrently with patient care. Preop-
erative transthoracic echocardiographic data were obtained from the
echocardiography database. The institutional review board approved the
use of these data for research, with the patient consent requirement waived.
Surgical Technique
General endotracheal anesthesia was used in all patients, regardless
of the surgical approach. Double-lumen intubation with single-lung
ventilation was used in operations performed by way of thoracotomy and
a robotic approach.7 The most common less-invasive approach was partial
upper sternotomy (167 patients [85%]) beginning at the sternal notch and
ending at the fourth intercostal space.8,9 Other approaches included partial
lower sternotomy (n ¼ 5), left thoracotomy (n ¼ 3), right thoracotomy
(n ¼ 4), right parasternal (n ¼ 4), transsternal (n ¼ 2), and robotic
(n ¼ 10) using previously described techniques.7,9,10 The type of
approach was reflective of individual surgeon preference.
Cardiopulmonary bypass (CPB) with vacuum-assisted venous drainage
and central or peripheral cannulation was used in all patients with normo-
thermic or mild hypothermia.11 Combined antegrade and retrograde blood
cardioplegia was used in all patients.
Endpoints
The primary efficiency endpoints were the CPB and myocardial ischemic
times. The safety of the operative approach was assessed by comparing
in-hospital mortality and morbidity, defined in accordance with the
Society of Thoracic Surgeons National Database (available at: http://www.
ctsnet.org/file/rptDataSpecifications252_1_ForVendorsPGS.pdf). Effective-
ness was assessed by long-term survival.
Follow-up
TheSocialSecurityDeathMasterFile, queriedonDecember22, 2010,was
used to identify patients’vital status.12,13Only 7 patients (0.8%) weremissing
follow-up data after hospital discharge, because no Social Security number
was available. A total of 4583 patient-years of passive follow-up data were
available for analysis. Mean follow-up was 5.2  4.1 years (median, 4.4),
with 25% of survivors followed up>9.3 years and 10%>12 years.Comparison Methods
Efficiency. CPB and myocardial ischemic times are summarized as
the mean  standard deviation, and comparisons were made using the
Wilcoxon rank sum test.162 The Journal of Thoracic and Cardiovascular SurgSafety. In-hospital mortality and morbidity are expressed as frequencies
and percentages, and comparisons were made using the chi-square test.
When the frequency was<5, Fisher’s exact test was used.
Effectiveness. Overall nonparametric survival estimates were
obtained using the Kaplan-Meier method and compared using the log-
rank test. A parametric model was used to resolve a number of phases of
instantaneous risk of death (hazard function) and to estimate shaping
parameters.14 (For additional details, see http://www.clevelandclinic.org/
heartcenter/hazard.)
All analyses were performed using SAS statistical software, version 9.1
(SAS Institute, Cary, NC). Percentages and parametric estimates are
accompanied by asymmetric 68% confidence limits (CLs), comparable
to 1 standard error.
Missing Values
A Markov chain Monte Carlo technique was used to impute
missing values as necessary,15 with fivefold multiple imputation for all
multivariable regression models performed using PROC MI and PROC
MIAnalyze (SAS, version 9.1).
Study Design
Comparisons adjusted for patient characteristics. Amean-
ingful direct comparison of outcomes was precluded by the differences in
patient characteristics (Table E1). To reduce the influence of selection bias,
we used propensity matching.16 Initially, the factors associated with
complete sternotomy were identified by ‘‘bagging’’ (automated forward
stepwise logistic regression using 1000 bootstrap resamplings and a P value
for variable retention of .05) using only patient characteristics (see the
Appendix).17 Variables identified in 50% of these models were retained
as a parsimonious model (Table E2).
To this model, other patient characteristics and intended procedure vari-
ables that might be related to unrecorded selection factors (semisaturated
model) were added (see the Appendix). A propensity score was calculated
for each patient by solving this model (C-statistic, 0.81) for the probability
of undergoing complete sternotomy. We used a ‘‘greedy’’ matching
strategy to match the less-invasive and complete sternotomy cases.18
Less-invasive cases with propensity scores deviating>0.10 from those of
full sternotomy were considered unmatched. This yielded 185 (90% of
possible matches) well-matched pairs (Figure E2). The effectiveness of
this matching strategy was evaluated by standardized differences of the
variables before and after matching (Figure E3). Characteristics of 185
matched patients and the procedures are listed in Table 1.
Comparison adjusted for surgeon preference. We further
accounted for surgeon preference by developing a second model with the
individual surgeons entered into the analysis (Table E3). The C-statistic
of this propensity model was 0.879. Greedy matching using propensity
scores yielded 139 (68% of patients undergoing less-invasive surgery)
well-matched pairs (Figure E4). The performance of this matching strategy
was evaluated by standardized differences of variables before and after
matching (Figure E5). The characteristics of these 139 matched patient
pairs and the procedures are listed in Table 1.RESULTS
Outcomes Adjusted for Patient Characteristics
Efficiency. Myocardial ischemic time (59 27 vs 64 26
minutes, P ¼ .04) was shorter with less-invasive surgery
than with complete sternotomy, as was the CPB time
(75  35 vs 86  33 minutes, P<.0001; Table 2, matched
group; Table E4, unmatched group).
In-hospital mortality was 1.6% (3 patients; 68% CL,
0.7-3.2%) in the less-invasive group and 2.7%ery c July 2014
TABLE 1. Patient characteristics and operative details
Variable
Groups matched on patient characteristics Groups matched on patient characteristics and surgeon
Complete sternotomy
(n ¼ 185)
Less invasive
(n ¼ 185)
P
value
Complete sternotomy
(n ¼ 139)
Less invasive
(n ¼ 139)
P
value
Patients*
(n)
No. (%) or
mean ± SD
Patients*
(n)
No. (%) or
mean ± SD
Patients*
(n)
No. (%) or
mean ± SD
Patients*
(n)
No. (%) or
mean ± SD
Demographics
Female gender 185 105 (57) 185 106 (57) .9 139 81 (58) 139 81 (58) >.9
Age (y) 185 66  14 185 66  14 .8 139 68  14 139 67  14 .4
BMI (kg/m2) 185 30  11 184 28  6.3 .4 139 29  8.4 138 29  6.9 .9
NYHA functional class 185 185 .9 139 139 .6
III 161 (87) 162 (88) 119 (86) 122 (88)
IV 24 (13) 23 (12) 20 (14) 17 (12)
LVEF (%) 184 52  14 184 53  12 .6 138 52  14 138 52  12 .6
Valve disease etiology
AV
Degenerative 185 80 (43) 185 73 (39) .5 139 67 (48) 139 60 (43) .4
Rheumatic 185 6 (3.2) 185 7 (3.8) .8 139 5 (3.6) 139 6 (4.3) .8
MV
Degenerative 185 76 (41) 185 79 (43) .8 139 55 (40) 139 49 (35) .5
Rheumatic 185 25 (14) 185 29 (16) .6 139 19 (14) 139 25 (18) .3
Functional 185 5 (2.7) 185 4 (2.2) .7 139 8 (5.8) 139 4 (2.9) .2
Indication for surgery
AV regurgitation 179 181 .8 134 135 .5
Moderately severe (3þ) 12 (6.7) 12 (6.6) 8 (6.0) 10 (7.4)
Severe (4þ) 10 (5.6) 9 (5.0) 8 (6.0) 7 (5.2)
AV stenosis 185 71 (38) 185 70 (38) .9 139 57 (41) 139 58 (42) .9
MV regurgitation 179 182 .6 137 135 .9
Moderately severe (3þ) 28 (16) 24 (13) 25 (18) 23 (17)
Severe (4þ) 67 (37) 70 (38) 47 (34) 43 (32)
MV stenosis 185 13 (7.0) 185 17 (9.2) .4 139 12 (8.6) 139 16 (12) .4
Comorbidities
Peripheral arterial disease 185 13 (7.0) 185 8 (4.3) .3 139 6 (4.3) 139 7 (5.0) .8
Carotid disease 185 43 (23) 185 40 (20) .7 139 38 (27) 139 31 (22) .3
Atrial fibrillation or flutter 183 37 (20) 185 37 (20) >.9 138 29 (21) 139 33 (24) .6
Stroke 185 12 (6.5) 185 13 (7.0) .8 139 13 (9.4) 139 11 (7.9) .7
Hypertension 185 110 (59) 185 111 (60) .9 139 90 (65) 139 88 (63) .8
Diabetes 180 22 (12) 178 18 (10) .5 136 11 (8.1) 133 8 (6.0) .5
Smoking 181 88 (49) 183 88 (48) .9 138 69 (50) 139 68 (49) .9
COPD 185 47 (25) 185 41 (22) .5 139 40 (29) 139 33 (24) .3
Creatinine (mg/dL) 184 1.08  0.69 184 1.2  1.07 .5 138 1.07  0.42 139 1.1  0.51 .6
BUN (mg/dL) 184 22  8.7 185 22  11 .6 138 23  9.6 139 23  11 .4
Operationy
AV repair 185 2 (1.1) 185 3 (1.6) — 139 2 (1.4) 139 3 (2.2) —
AV replacement 185 75 (40) 185 69 (37) .5 139 52 (37) 139 56 (40) .6
AV repair þ MV repair 185 0 (0) 185 0 (0) — 139 0 (0) 139 0 (0) —
AV replacement þ MV
repair
185 5 (2.7) 185 3 (1.6) — 139 3 (2.2) 139 3 (2.2) —
AV replacement þ MV
replacement
185 4 (2.2) 185 3 (1.6) — 139 11 (7.9) 139 2 (1.4) —
AV repair þ MV
repair þ TV
185 0 (0) 185 2 (1.1) — 139 1 (0.72) 139 2 (1.4) —
AV replacement þ MV
repair þ TV
185 1 (0.54) 185 0 (0) — 139 2 (1.4) 139 0 (0) —
AV replacement þ MV
replacement þ TV
185 0 (0) 185 0 (0) — 139 1 (0.72) 139 0 (0) —
(Continued)
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TABLE 1. Continued
Variable
Groups matched on patient characteristics Groups matched on patient characteristics and surgeon
Complete sternotomy
(n ¼ 185)
Less invasive
(n ¼ 185)
P
value
Complete sternotomy
(n ¼ 139)
Less invasive
(n ¼ 139)
P
value
Patients*
(n)
No. (%) or
mean ± SD
Patients*
(n)
No. (%) or
mean ± SD
Patients*
(n)
No. (%) or
mean ± SD
Patients*
(n)
No. (%) or
mean ± SD
AV replacement þ TV 185 1 (0.54) 185 1 (0.54) — 139 1 (0.72) 139 1 (0.72) —
MV repair 185 56 (30) 185 72 (39) .08 139 41 (29) 139 1 (29) >.9
MV replacement 185 30 (16) 185 19 (10) .09 139 16 (11) 139 0 (14) .5
MV repair þ TV 185 6 (3.2) 185 10 (5.4) — 139 5 (3.6) 139 8 (5.8) —
MV replacement þ TV 185 5 (2.7) 185 3 (1.6) — 139 4 (2.9) 139 3 (2.2) —
BMI, Body mass index; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; AV, aortic valve;MV, mitral valve; COPD, chronic obstructive pulmonary
disease; BUN, blood urea nitrogen; TV, tricuspid valve surgery; SD, standard deviation. *Patients with data available. yIn all categories, surgery could include a procedure for atrial
fibrillation.
Acquired Cardiovascular Disease Mihaljevic et al
A
C
D(5 patients; 68% CL, 1.5-4.5%) in the complete sternot-
omy group (P ¼ .5; Table 3, matched group; Table E5,
unmatched group). The mode of death in the less-
invasive group was multisystem organ failure in 1, acute
pulmonary and kidney failure leading to multisystem or-
gan failure in 1, and a perforated esophagus while inves-
tigating marked leukocytosis and fever, leading to
cardiac tamponade, reoperation, metabolic acidosis,
and cardiac arrest in 1. The mode of failure in the com-
plete sternotomy group was acute cardiac failure in
2, neurologic in 1, multisystem organ failure in 1, and
respiratory failure and sepsis leading to multisystem
organ failure in 1.
In-hospital complications occurred with a similar fre-
quency, with new-onset atrial fibrillation (36% vs 32%,
P ¼ .5; 68% CL, 32-41% vs 28-37%) the most common
complication. Other commonly observed complications in
both groups were renal failure (7% vs 8%, P ¼ .7; 68%
CL, 5.2-9.4% vs 6.1-11%) and prolonged ventilation
(13% vs 8%, P ¼ .2; 68% CL, 10-16% vs 7.1-12%;
Table 3, matched group; Table E5, unmatched group).
The intensive care unit length of stay (median, 24 vs
43 hours; P ¼ .007) was shorter in the less-invasive group,
and the postoperative length of stay (median, 7 days for
both; P ¼ .10) was similar (Table 2).
Effectiveness. Adjusted survival at 30 days and 5 and 10
years was 98%, 79%, and 61% after less-invasive surgery
and 97%, 75%, and 55% after complete sternotomy,TABLE 2. Operative times and length of stay for propensity-matched gro
Variable
Groups matched on patient character
Complete sternotomy Less invasive P
Operative time (min)
Cardiopulmonary bypass 86  34 75  35 <
Myocardial ischemic 64  26 59  27
Postoperative management
ICU length of stay (h) 24/43/117 24/24/96
Postoperative length of stay (d) 5/7/13 5/7/12
Data presented as mean  standard deviation or 15th/50th/85th percentiles. ICU, Intensiv
164 The Journal of Thoracic and Cardiovascular Surgrespectively (P ¼ .3; Figure 1, A, matched group;
Figure E6, unmatched group).
Outcomes Adjusted for Surgeon Preference
Efficiency. Among the patients propensity matched for
both patient characteristics and surgeon, the myocardial
ischemic time (63  30 vs 62  25 minutes, P ¼ .8) and
CPB time (80 40 vs 81 31 minutes, P¼.5) were similar
(Table 2).
Safety. In-hospital mortality was similar after less-invasive
surgery (3 patients, 2.2%; 68% CL, 0.9-4.2%) and com-
plete sternotomy (5 patients, 3.6%; 68% CL, 2.1-5.9%;
P ¼ .5; Table 3, matched group; Table E5, unmatched
group). In-hospital complications occurred with a similar
frequency, with new-onset atrial fibrillation (35% vs
36%, P¼ .9; 68% CL, 30-40% vs 31-41%) the most com-
mon complication. Less-invasive surgery was associated
with a lower prevalence of prolonged ventilation (9.4%
vs 17%, P¼ .05; 68% CL, 6.9-13% vs 14-21%) and fewer
Society of Thoracic Surgeons–defined complications (18%
vs 32%, P ¼ .005; 68% CL, 15-22% vs 28-36%; Table 3,
matched group; Table E4, unmatched group). The intensive
care unit (median, 28 vs 30 hours; P ¼ .09) and hospital
(median, 9 days for both groups; P ¼ .14) lengths of stay
were similar (Table 2).
Effectiveness. Adjusted survival at 5 and 10 years was
77% and 57% after less-invasive surgery and 74% and
53% after complete sternotomy (P ¼ .5; Figure 1, B).ups
istics Groups matched on patient characteristics and surgeon
value Complete sternotomy Less invasive P value
.0001 81  31 80  40 .5
.04 62  26 63  30 .8
.007 24/30/124 24/28/100 .09
.104 5/7/14 5/7/12 .2
e care unit.
ery c July 2014
TABLE 3. Postoperative complications and in-hospital mortality for propensity-matched groups
Variable
Groups matched on patient characteristics Groups matched on patient characteristics and surgeon
Complete sternotomy
(n ¼ 185)
Less invasive
(n ¼ 185)
P
value
Complete sternotomy
(n ¼ 139)
Less invasive
(n ¼ 139)
P
value
Patients*
(n) No. (%)
Patients*
(n) No. (%)
Patients*
(n) No. (%)
Patients*
(n) No. (%)
Complications
Atrial fibrillation or fluttery 146 53 (36) 148 48 (32) .5 109 39 (36) 106 37 (35) .9
Prolonged ventilation (>24 h) 185 24 (13) 182 17 (9.2) .2 139 24 (17) 139 13 (9.4) .05
Renal failure requiring
dialysisz
169 2 (1.2) 179 4 (2.2) .4 132 1 (0.76) 134 3 (2.2) .3
Return to OR for bleeding 185 9 (4.9) 185 5 (2.7) .3 139 4 (2.9) 139 2 (1.4) .4
Septicemia 185 3 (1.6) 185 6 (3.2) .3 139 4 (2.9) 139 5 (3.6) .7
Stroke 185 3 (1.6) 185 1 (0.54) .3 139 4 (2.9) 139 1 (0.72) .18
Deep sternal wound infection 185 3 (1.6) 185 2 (1.1) .6 139 2 (1.4) 139 1 (0.72) .6
Perioperative MI 185 0 (0) 185 2 (1.1) .16 139 0 (0) 139 2 (1.4) .16
Mechanical circulatory support
Intra-aortic balloon pump 185 1 (0.54) 185 1 (0.54) >.9 139 1 (0.72) 139 1 (0.72) >.9
Mortality
In-hospital 185 5 (2.7) 185 3 (1.6) .5 139 5 (3.6) 139 3 (2.2) .5
30-d 183 6 (3.3) 184 6 (3.3) >.9 138 4 (2.9) 138 6 (4.3) .5
Operative 183 6 (3.3) 184 6 (3.3) >.9 138 5 (3.6) 138 6 (4.3) .8
OR, Operating room;MI, myocardial infarction. *Patients with data available. yDenominator did not include patients with preoperative atrial fibrillation. zDenominator did not
include patients requiring dialysis preoperatively.
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Rheumatic valve disease (P ¼ .04), functional mitral
regurgitation (P ¼ .0003), mitral valve replacement
(P¼ .0003), and a concomitant ablative procedure for atrial
fibrillation (P<.0001) were associated with more frequent
use of complete sternotomy. This was true among the 3 sur-
geons who otherwise often preferred less-invasive surgery
(Tables E6 and E7).
DISCUSSION
The increased prevalence of heart failure requiring heart
valve surgery has resulted in part from the aging of the pop-
ulation. However, nearly one third of patients with severe
heart valve disease who could benefit from surgery do not
undergo surgery because of the high risks secondary to their
heart failure, comorbidities, and older age.4 For these pa-
tients, the reduced trauma from a less-invasive approach
could be beneficial.
Although several observational studies have shown ben-
efits from less-invasive valve surgery, no randomized trials
of less-invasive approaches versus complete sternotomy
have been conducted.2,8,19,20 A recent observational study
from EIBardissi and colleagues3 showed that less-invasive
surgery is feasible in high-risk patients requiring aortic
valve replacement. Other studies have reported compar-
able results, with the advantages of fewer transfusions,
better respiratory function, less early postoperative pain
and improved cosmesis, a comparable or shorter
length of stay, and similar long-term survival.1-4,6,19,21-24
For high-risk patients such as the elderly and obese,The Journal of Thoracic and Caless-invasive surgery has been associated with reduced
mortality.25,26
A challenge in designing either a randomized trial or an
observation study on this topic is the disparity between the
development of severe functional disability from heart
failure secondary to the valvular heart disease and the
typical measurements of heart function. For example, in
patients with severe aortic stenosis, ejection fraction is
generally normal; diastolic dysfunction from severe
ventricular hypertrophy is what leads to heart failure, an
enlarged left atrium,27 and a poor prognosis. Patients with
severe mitral valve regurgitation will have an artificially
elevated ejection fraction because of backflow into the
low-pressure left atrium. In both instances, a lower than
normal ejection fraction (low flow, low gradient aortic
stenosis, or nonischemic dilated cardiomyopathy) portends
severe end-stage disease. Thus, in designing the present
study, we focused on patients with severe limitations
from heart failure, with or without an abnormal ejection
fraction. This degree of heart failure is unusual—only
8% of our experience—making a randomized trial chal-
lenging to enroll.
Principal Findings
The present study confirms that efficiency, safety,
and effectiveness advantages exist with less-invasive
surgery for patients with severe heart failure. Although
patients undergoing less-invasive surgery experience
shorter operative times and intensive care unit and
hospital lengths of stay than those undergoing completerdiovascular Surgery c Volume 148, Number 1 165
FIGURE 1. Survival after heart valve procedure in propensity-matched patients. Each symbol represents a death positioned on the vertical axis by the
Kaplan-Meier estimator. Vertical bars represent asymmetric 68% confidence limits equivalent to1 standard error. Solid lines indicate parametric survival
estimates enclosed within dashed 68% confidence bands equivalent to 1 standard error. Numbers in parentheses represent patients remaining at risk.
A, Stratified by surgical approach (blue lines and open circles indicate less-invasive approach; red lines and closed circles, complete sternotomy) for patients
matched only on preoperative patient characteristics. B, Stratified by surgical approach for patients matched for both patient characteristics and surgeon.
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selection appeared to be influenced by the presence of
comorbidities (eg, diabetes) and cardiac morphology
and function (eg, larger left atrial diameter, greater left
ventricular end-systolic volume, and mitral valve stenosis;
Table E2).
Additional investigation of operative times and lengths
of stay suggested that the differences between less-
invasive approaches and complete sternotomy reflect
surgeon preference rather than the approach itself. In our
group, 3 surgeons preferred the less-invasive approach
and used it in many patients. Patient characteristics (lower
body mass index, less concomitant vascular disease) and
intended procedure factors (mitral and tricuspid valve166 The Journal of Thoracic and Cardiovascular Surgsurgery) were associated with less-invasive surgery and
were all included in the propensity model. After account-
ing for surgeon preference, the advantages of less-invasive
surgery (shorter operative times and length of postopera-
tive stay) were no longer apparent. These findings indicate
that most patients with severe heart failure underwent
surgery by surgeons with expertise in less-invasive sur-
gery. Thus, after adjusting for surgeon characteristics,
the previously observed benefits no longer prevailed.
The surgeons who preferred less-invasive surgery in
everyday practice tended to be more efficient. Never-
theless, the 3 surgeons with expertise in less-invasive
approaches decided to use complete sternotomy in 50%
of their patients with heart failure.ery c July 2014
Mihaljevic et al Acquired Cardiovascular DiseaseThe choice of a less-invasive approach was informed by
the disease etiology. A partial upper sternotomy was the
most commonly used approach because of its versatility,
allowing access to all the heart valves.A
C
DStudy Limitations
Our analysis had several limitations. First, our study was
a clinical observation study and not a randomized trial.
Thus, it was subject to multiple real and potential biases.
Selection biases cannot be completely eliminated using a
propensity-matching approach; however, 90% of the orig-
inal cohort was matched, with the matched patient pairs
distributed across a range of propensity scores. Second,
when a propensity score was used to match the patients,
the differences in most outcomes appeared to be explained
by differences in patient characteristics and surgeon prefer-
ence. We acknowledged this selection bias by introducing
additional matching that included surgeons as a variable.
In that analysis, 68% of the original cohort was matched,
because of a lack of patients within portions of the propen-
sity spectrum. However, the matches covered large parts of
the spectrum. Third, this was a single-institution study,
limiting its generalizability. Fourth, at present, our preferred
less-invasive approach for treating mitral valve disease is a
right anterior minithoracotomy, with or without robotic
instrumentation. However, because of its relatively recent
adoption since 2006, these approaches were not fully
represented in the present analyses.CONCLUSIONS
In selected patients with severe heart failure, less-
invasive valve surgery is a viable option, yielding at least
equivalent efficiency, safety, and effectiveness compared
with complete sternotomy. However, achieving these out-
comes requires surgeons experienced in less-invasive surgi-
cal techniques.
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DAPPENDIX. VARIABLES USED IN THE ANALYSIS
Preoperative
Demographic. Age (y),* gender,* race,* height (cm),
weight (kg), body mass index (kg/m2),* body surface
area (m2)
Symptoms. Dyspnea on exertion,* dyspnea at rest, parox-
ysmal nocturnal dyspnea, orthopnea,* peripheral edema
Ventricular function. Previous myocardial infarction, left
ventricular ejection fraction (%),* fractional shortening
Left ventricular size. Left ventricular end-diastolic vol-
ume (mL), left ventricular end-systolic volume (mL),*
left ventricular diastolic diameter (cm), left ventricular sys-
tolic diameter (cm),* left ventricular mass (g), posterior
wall thickness (cm), septal thickness (cm)
Left atrium. Left atrial diameter (cm),* left atrial volume
(mL)*
Valve pathology. Aortic valve regurgitation,* aortic valve
stenosis,* mitral valve regurgitation, mitral valve stenosis,*FIGURE E1. CONSORT (CONsolidated Standards of Reporting Trials)-
style diagram of patient population. TAVR, Transcatheter aortic valve
replacement; NYHA, New York Heart Association.
*Variables in patient characteristics propensity model.
167.e1 The Journal of Thoracic and Cardiovascular Stricuspid valve regurgitation,* tricuspid valve stenosis, pul-
monary valve regurgitation, pulmonary valve stenosis
Cardiac comorbidity. Complete heart block,* ventricular
arrhythmia, chronic heart failure,* previous cardiac surgery,
atrial fibrillation or flutter*
Noncardiac comorbidity. Hypertension,* peripheral arte-
rial disease, diabetes,* stroke, smoking,* renal disease,
chronic obstructive pulmonary disease,* blood urea nitro-
gen (mg/dL),* creatinine (mg/dL),* hematocrit (%),* bili-
rubin (mg/dL)*Intraoperative
Procedure. Aortic valve,* mitral valve,* tricuspid valve,*
atrial septal defect/patent foramen ovale, maze*
Experience. Time from study entry*
Surgeon. A,y B,y C,y D, E, F, G, H,y I, J,y K, L,yM,y N,y
O, P,y Q, R, S,y TFIGURE E2. Mirrored histogram of distribution of propensity scores for
complete sternotomy versus less-invasive groups. Darkened area repre-
sents matched patient pairs for patient characteristics.
yUsed in propensity matching with surgeon.
urgery c July 2014
FIGURE E3. Covariable balance description before (blue triangles) and after (red squares) matching between complete sternotomy and less-invasive
groups matched for patient characteristics. AV, Aortic valve; regurg, regurgitation, MV, mitral valve; Afib, atrial fibrillation; LA, left atrial.
FIGURE E4. Mirrored histogram of distribution of propensity scores for
complete sternotomy versus less-invasive groups. Darkened area repre-
sents matched pairs for both patient characteristics and surgeon variables.
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FIGURE E5. Covariable balance description before (blue triangles) and after (red squares) matching between complete sternotomy and less-invasive
groups matched for both patient characteristics and surgeon factors. AV, Aortic valve; regurg, regurgitation; MV, mitral valve; Afib, atrial fibrillation;
LA, left atrial.
FIGURE E6. Unadjusted survival after valve procedure stratified by surgical approach. Each symbol represents a death positioned on the vertical axis by
the Kaplan-Meier estimator. Vertical bars represent asymmetric 68% confidence limits equivalent to 1 standard error. Solid lines are parametric survival
estimates enclosed within dashed 68% confidence bands equivalent to 1 standard error. Numbers in parentheses represent patients remaining at risk.
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TABLE E1. Patient characteristics and operative details
Variable
Overall group
Complete sternotomy (n ¼ 666) Less invasive (n ¼ 205)
P valuePatients* (n) No. (%) or mean ± SD Patients* (n) No. (%) or mean ± SD
Demographics
Female gender 666 407 (61) 205 118 (58) .4
Age (y) 666 67  14 205 66  14 .2
BMI (kg/m2) 666 29  8.8 204 28  6.2 .4
NYHA functional class 666 205 .5
III 570 (86) 179 (87)
IV 96 (14) 26 (13)
LVEF (%) 649 48  15 204 53  12 <.0001
Valve disease etiology
AV
Degenerative 666 280 (42) 205 77 (38) .2
Rheumatic 666 57 (8.6) 205 7 (3.4) .01
MV
Degenerative 666 242 (36) 205 90 (44) .05
Rheumatic 666 154 (23) 205 33 (16) .03
Functional 666 78 (12) 205 4 (2.0) <.0001
Indication for surgery
AV regurgitation 630 198
Moderately severe (3þ) 64 (10) 13 (6.6)
Severe (4þ) 33 (5.2) 9 (4.5)
AV stenosis 666 312 (47) 205 71 (35) .002
MV regurgitation 644 201
Moderately severe (3þ) 149 (23) 26 (13)
Severe (4þ) 217 (34) 83 (41)
MV stenosis 666 121 (18) 205 18 (8.8) .001
Comorbidities
Peripheral arterial disease 666 37 (5.6) 205 9 (4.4) .5
Carotid disease 666 186 (28) 205 40 (20) .02
Atrial fibrillation or flutter 656 214 (33) 205 42 (20) .0001
Stroke 666 61 (9.2) 205 13 (6.3) .2
Hypertension 666 437 (66) 205 118 (58) .04
Diabetes 644 133 (21) 198 18 (9.1) .0002
Smoking 658 333 (51) 203 95 (47) .3
COPD 666 186 (28) 205 44 (21) .07
Creatinine (mg/dL) 663 1.2  0.87 204 1.2  1.05 .18
BUN (mg/dL) 663 25  13 205 22  11 .002
Operationy
AV repair 666 3 (0.45) 205 4 (2.0) —
AV replacement 666 169 (25) 205 72 (35) .006
AV repair þ MV repair 666 2 (0.30) 205 0 (0) —
AV replacement þ MV repair 666 42 (6.3) 205 3 (1.5) —
AV replacement þ MV replacement 666 57 (8.6) 205 3 (1.5) —
AV repair þ MV repair þ TV 666 4 (0.60) 205 2 (1.0) —
AV replacement þ MV repair þ TV 666 26 (3.9) 205 0 (0) —
AV replacement þ MV replacement þ TV 666 31 (4.6) 205 0 (0) —
AV replacement þ TV 666 13 (2.0) 205 1 (0.49) —
MV repair 666 108 (16) 205 84 (41) <.0001
MV replacement 666 87 (13) 205 23 (11) .5
MV repair þ TV 666 61 (9.2) 205 10 (4.9) —
MV replacement þ TV 666 63 (9.5) 205 3 (1.5) —
BMI, Body mass index; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; AV, aortic valve; MV, mitral valve; COPD, chronic obstructive
pulmonary disease; BUN, blood urea nitrogen; TV, tricuspid valve surgery. SD, standard deviation. *Patients with data available. yIn all categories, operation could include
procedure for atrial fibrillation.
Mihaljevic et al Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 1 167.e4
A
C
D
TABLE E2. Patient characteristics associated with complete
sternotomy, not considering surgeon
Characteristic Coefficient ± SE
P
value
Reliability*
(%)
Aortic valve regurgitation 0.61  0.17 .0004 93
Diabetes 0.87  0.28 .003 69
Greater LV end-systolic
volume
0.0056  0.0021 .009 75
Larger left atrial diameter 0.24  0.101 .02 72
Mitral valve stenosis 0.82  0.27 .003 82
The C-statistic for this parsimonious model was 0.68. SE, Standard error; LV, left
ventricular. *Percentage of times the factor appeared in 1000 bootstrap models.
TABLE E3. Factors associated with surgical approach, considering
surgeon
Factor Coefficient ± SE
P
value
Reliability*
(%)
Associated with
less-invasive approach
Surgeon A 2.85  0.28 <.0001 100
Surgeon B 1.89  0.37 <.0001 100
Surgeon C 1.89  0.46 <.0001 100
More recent date of
surgeryy
2.38  0.45 <.0001 99
Lower LV end-systolic
volume (mL/m2)
0.017  0.0056 .004 86
Associated with complete
sternotomy
Aortic valve regurgitation 0.81  0.22 .0003 71
Aortic valve stenosis 1.09  0.29 .0002 71
Mitral valve operation 1.87  0.32 <.0001 97
Tricuspid valve operation 1.39  0.33 <.0001 97
Higher body mass index 0.04  0.015 .004 65
More recent date of surgery 0.34  0.074 <.0001 99
History of hypertension 0.50  0.23 .03 92
History of carotid disease 0.56  0.26 .03 92
The C-statistic for this parsimonious model was 0.84. SE, Standard error; LV, left ven-
tricular. *Percentage of times the factor appeared in 1000 bootstrap models.
yLn(years from January 1995), logarithmic transformation.
TABLE E4. Operative times and length of stay for entire cohort
Variable
Complete sternotomy
(n ¼ 666)
Less invasive
(n ¼ 205)
P
value
Operative times (min)
Cardiopulmonary
bypass
98  37 75  35 <.0001
Myocardial
ischemic
75  30 60  27 <.0001
Postoperative
management
ICU length of
stay (h)
24/48/145 24/26/96 <.0001
Postoperative length
of stay (d)
6/8/16 5/7/12 <.0001
Data presented as mean  standard deviation or 15th/50th/85th percentiles.
ICU, Intensive care unit.
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TABLE E5. Postoperative complications and in-hospital mortality for entire cohort
Variable
Complete sternotomy (n ¼ 666) Less invasive (n ¼ 205)
P valuePatients* (n) No. (%) Patients* (n) No. (%)
Complications
Atrial fibrillation or fluttery 443 152 (34) 163 53 (33) .7
Prolonged ventilation (>24 h) 666 137 (21) 205 17 (8.3) <.001
Renal failure requiring dialysisz 594 19 (3.2) 199 4 (2.0) .4
Return to OR for bleeding 666 32 (4.8) 205 5 (2.4) .14
Septicemia 666 21 (3.2) 205 6 (2.9) .9
Stroke 666 17 (2.6) 205 1 (0.49) .07
Deep sternal wound infection 666 7 (1.1) 205 2 (0.98) .9
Perioperative MI 666 2 (0.3) 205 2 (0.98) .2
Mechanical circulatory support
Intra-aortic balloon pump 666 2 (0.3) 205 1 (0.49) .7
Mortality
In-hospital 666 21 (3.2) 205 4 (2.0) .4
30-d 660 27 (4.1) 204 7 (3.4) .7
Operative 660 32 (4.8) 204 7 (3.4) .4
OR, Operating room;MI,myocardial infarction. *Patients with data available. yDenominator did not include patients with preoperative atrial fibrillation or flutter. zDenominator
did not include patients requiring dialysis preoperatively.
TABLE E6. Factors associated with surgical approach in 3 surgeons’
practices
Factor Coefficient ± SE
P
value
Reliability*
(%)
Associated with less-invasive
approach
Lower LV end-diastolic
volume (mL/m2)
0.018  0.0056 .002 64
Any valve with
degenerative etiology
1.3  0.36 .0002 54
Associated with complete
sternotomy
Aortic valve stenosis 0.74  0.31 .02 51
History of hypertension 0.97  0.33 .003 91
Any valve with functional
regurgitation
1.6  0.45 .0004 74
The C-statistic of this parsimonious model was 0.72. SE, Standard error; LV, left
ventricular. *Percentage of times the factor appeared in 1000 bootstrap models.
TABLE E7. Surgical approach in three surgeons’ practices
Surgeon
Overall
Groups matched on
patient characteristics
Groups matched on patient
characteristics and surgeon
Total
patients (n)
Complete
sternotomy
(n ¼ 106)
Less invasive
(n ¼ 131)
Total
patients (n)
Complete
sternotomy
(n ¼ 31)
Less invasive
(n ¼ 120)
Total
patients
(n)
Complete
sternotomy
(n ¼ 63)
Less invasive
(n ¼ 66)
A 154 61 (40) 93 (60) 106 17 (16) 89 (84) 80 37 (46) 43 (54)
B 52 29 (56) 23 (44) 26 8 (31) 18 (69) 29 16 (55) 13 (45)
C 33 18 (55) 15 (45) 19 6 (32) 13 (68) 20 10 (50) 10 (50)
Data presented as No. (%).
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